Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Rowe

Showing results (181-190 of 205) with videos related to

Pageof 21
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490)C L Bennett, T J Stinson, M S Tallman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcomeA P Rapoport, J M Rowe, P A Kouides, et al.
Journal of Cancer Research and Clinical Oncology|June 11, 1999
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromesW Verbeek, B Wörmann, P Koch, et al.
Blood|July 15, 1995
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)J M Rowe, J W Andersen, J J Mazza, et al.
The New England Journal of Medicine|October 9, 1997
All-trans-retinoic acid in acute promyelocytic leukemiaM S Tallman, J W Andersen, C A Schiffer, et al.
Blood|December 23, 1999
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndromeM S Tallman, J W Andersen, C A Schiffer, et al.
Bone Marrow Transplantation|March 15, 2016
Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullaryJ M Watts, X V Wang, R T Swords, et al.
Bone Marrow Transplantation|December 1, 1999
Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimexJ M Rowe, A P Rapoport, D H Ryan, et al.
Blood|December 9, 2000
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group StudyM L Slovak, K J Kopecky, P A Cassileth, et al.
The New England Journal of Medicine|December 3, 1998
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remissionP A Cassileth, D P Harrington, F R Appelbaum, et al.
Pageof 21

Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490)C L Bennett, T J Stinson, M S Tallman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcomeA P Rapoport, J M Rowe, P A Kouides, et al.
Journal of Cancer Research and Clinical Oncology|June 11, 1999
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromesW Verbeek, B Wörmann, P Koch, et al.
Blood|July 15, 1995
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)J M Rowe, J W Andersen, J J Mazza, et al.
The New England Journal of Medicine|October 9, 1997
All-trans-retinoic acid in acute promyelocytic leukemiaM S Tallman, J W Andersen, C A Schiffer, et al.
Blood|December 23, 1999
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndromeM S Tallman, J W Andersen, C A Schiffer, et al.
Bone Marrow Transplantation|March 15, 2016
Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullaryJ M Watts, X V Wang, R T Swords, et al.
Bone Marrow Transplantation|December 1, 1999
Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimexJ M Rowe, A P Rapoport, D H Ryan, et al.
Blood|December 9, 2000
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group StudyM L Slovak, K J Kopecky, P A Cassileth, et al.
The New England Journal of Medicine|December 3, 1998
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remissionP A Cassileth, D P Harrington, F R Appelbaum, et al.
Pageof 21